Tag: Dr Angus Forster
Vaxxas secures TGA licence to expand manufacturing of therapeutic goods in Brisbane
Australian biotechnology company Vaxxas has been granted a Therapeutic Goods Administration licence to manufacture therapeutic goods, clearing the way for GMP-compliant manufacturing at its Brisbane biomedical facility and supporting the progression of clinical trials for its proprietary high-density microarray patch technology.














